COVID-19 Impact on Global Optic Neuritis Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C80A6A000C2CEN
QYResearch

Abstracts

This report focuses on the global Optic Neuritis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Optic Neuritis Treatment development in North America, Europe, China and Japan.
The key players covered in this study

• Pfizer
• Sanofi
• Allergan
• Bristol-Meyers Squibb
• Novartis
• Healthy Life Pharma
• Fresenius Kabi USA
• Hikama
• AdvaCare Pharma

Market segment by Type, the product can be split into

• Intravenous
• Oral

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Optic Neuritis Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Optic Neuritis Treatment development in North America, Europe, China and Japan.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Optic Neuritis Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Optic Neuritis Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Optic Neuritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Intravenous
  1.4.3 Oral
1.5 Market by Application
  1.5.1 Global Optic Neuritis Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Optic Neuritis Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Optic Neuritis Treatment Industry
    1.6.1.1 Optic Neuritis Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Optic Neuritis Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Optic Neuritis Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Optic Neuritis Treatment Market Perspective (2015-2026)
2.2 Optic Neuritis Treatment Growth Trends by Regions
  2.2.1 Optic Neuritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Optic Neuritis Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Optic Neuritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Optic Neuritis Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Optic Neuritis Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Optic Neuritis Treatment Players by Market Size
  3.1.1 Global Top Optic Neuritis Treatment Players by Revenue (2015-2020)
  3.1.2 Global Optic Neuritis Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Optic Neuritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Optic Neuritis Treatment Market Concentration Ratio
  3.2.1 Global Optic Neuritis Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Optic Neuritis Treatment Revenue in 2019
3.3 Optic Neuritis Treatment Key Players Head office and Area Served
3.4 Key Players Optic Neuritis Treatment Product Solution and Service
3.5 Date of Enter into Optic Neuritis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Optic Neuritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Optic Neuritis Treatment Forecasted Market Size by Type (2021-2026)

5 OPTIC NEURITIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Optic Neuritis Treatment Market Size by Application (2015-2020)
5.2 Global Optic Neuritis Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Optic Neuritis Treatment Market Size (2015-2020)
6.2 Optic Neuritis Treatment Key Players in North America (2019-2020)
6.3 North America Optic Neuritis Treatment Market Size by Type (2015-2020)
6.4 North America Optic Neuritis Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Optic Neuritis Treatment Market Size (2015-2020)
7.2 Optic Neuritis Treatment Key Players in Europe (2019-2020)
7.3 Europe Optic Neuritis Treatment Market Size by Type (2015-2020)
7.4 Europe Optic Neuritis Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Optic Neuritis Treatment Market Size (2015-2020)
8.2 Optic Neuritis Treatment Key Players in China (2019-2020)
8.3 China Optic Neuritis Treatment Market Size by Type (2015-2020)
8.4 China Optic Neuritis Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Optic Neuritis Treatment Market Size (2015-2020)
9.2 Optic Neuritis Treatment Key Players in Japan (2019-2020)
9.3 Japan Optic Neuritis Treatment Market Size by Type (2015-2020)
9.4 Japan Optic Neuritis Treatment Market Size by Application (2015-2020)

10 KEY PLAYERS PROFILES

10.1 Pfizer
  10.1.1 Pfizer Company Details
  10.1.2 Pfizer Business Overview and Its Total Revenue
  10.1.3 Pfizer Optic Neuritis Treatment Introduction
  10.1.4 Pfizer Revenue in Optic Neuritis Treatment Business (2015-2020))
  10.1.5 Pfizer Recent Development
10.2 Sanofi
  10.2.1 Sanofi Company Details
  10.2.2 Sanofi Business Overview and Its Total Revenue
  10.2.3 Sanofi Optic Neuritis Treatment Introduction
  10.2.4 Sanofi Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.2.5 Sanofi Recent Development
10.3 Allergan
  10.3.1 Allergan Company Details
  10.3.2 Allergan Business Overview and Its Total Revenue
  10.3.3 Allergan Optic Neuritis Treatment Introduction
  10.3.4 Allergan Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.3.5 Allergan Recent Development
10.4 Bristol-Meyers Squibb
  10.4.1 Bristol-Meyers Squibb Company Details
  10.4.2 Bristol-Meyers Squibb Business Overview and Its Total Revenue
  10.4.3 Bristol-Meyers Squibb Optic Neuritis Treatment Introduction
  10.4.4 Bristol-Meyers Squibb Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.4.5 Bristol-Meyers Squibb Recent Development
10.5 Novartis
  10.5.1 Novartis Company Details
  10.5.2 Novartis Business Overview and Its Total Revenue
  10.5.3 Novartis Optic Neuritis Treatment Introduction
  10.5.4 Novartis Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.5.5 Novartis Recent Development
10.6 Healthy Life Pharma
  10.6.1 Healthy Life Pharma Company Details
  10.6.2 Healthy Life Pharma Business Overview and Its Total Revenue
  10.6.3 Healthy Life Pharma Optic Neuritis Treatment Introduction
  10.6.4 Healthy Life Pharma Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.6.5 Healthy Life Pharma Recent Development
10.7 Fresenius Kabi USA
  10.7.1 Fresenius Kabi USA Company Details
  10.7.2 Fresenius Kabi USA Business Overview and Its Total Revenue
  10.7.3 Fresenius Kabi USA Optic Neuritis Treatment Introduction
  10.7.4 Fresenius Kabi USA Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.7.5 Fresenius Kabi USA Recent Development
10.8 Hikama
  10.8.1 Hikama Company Details
  10.8.2 Hikama Business Overview and Its Total Revenue
  10.8.3 Hikama Optic Neuritis Treatment Introduction
  10.8.4 Hikama Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.8.5 Hikama Recent Development
10.9 AdvaCare Pharma
  10.9.1 AdvaCare Pharma Company Details
  10.9.2 AdvaCare Pharma Business Overview and Its Total Revenue
  10.9.3 AdvaCare Pharma Optic Neuritis Treatment Introduction
  10.9.4 AdvaCare Pharma Revenue in Optic Neuritis Treatment Business (2015-2020)
  10.9.5 AdvaCare Pharma Recent Development

11 ANALYST'S VIEWPOINTS/CONCLUSIONS

12 APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Optic Neuritis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Optic Neuritis Treatment Revenue
Table 3. Ranking of Global Top Optic Neuritis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Optic Neuritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous
Table 6. Key Players of Oral
Table 7. COVID-19 Impact Global Market: (Four Optic Neuritis Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Optic Neuritis Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Optic Neuritis Treatment Players to Combat Covid-19 Impact
Table 12. Global Optic Neuritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Optic Neuritis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Optic Neuritis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Optic Neuritis Treatment Market Share by Regions (2015-2020)
Table 16. Global Optic Neuritis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Optic Neuritis Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Optic Neuritis Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Optic Neuritis Treatment Players
Table 23. Global Optic Neuritis Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Optic Neuritis Treatment Market Share by Players (2015-2020)
Table 25. Global Top Optic Neuritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Optic Neuritis Treatment as of 2019)
Table 26. Global Optic Neuritis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Optic Neuritis Treatment Product Solution and Service
Table 29. Date of Enter into Optic Neuritis Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Optic Neuritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Optic Neuritis Treatment Market Size Share by Type (2015-2020)
Table 33. Global Optic Neuritis Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Optic Neuritis Treatment Market Size Share by Application (2015-2020)
Table 35. Global Optic Neuritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Optic Neuritis Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Optic Neuritis Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Optic Neuritis Treatment Market Share (2019-2020)
Table 39. North America Optic Neuritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Optic Neuritis Treatment Market Share by Type (2015-2020)
Table 41. North America Optic Neuritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Optic Neuritis Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Optic Neuritis Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Optic Neuritis Treatment Market Share (2019-2020)
Table 45. Europe Optic Neuritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Optic Neuritis Treatment Market Share by Type (2015-2020)
Table 47. Europe Optic Neuritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Optic Neuritis Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Optic Neuritis Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Optic Neuritis Treatment Market Share (2019-2020)
Table 51. China Optic Neuritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Optic Neuritis Treatment Market Share by Type (2015-2020)
Table 53. China Optic Neuritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Optic Neuritis Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Optic Neuritis Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Optic Neuritis Treatment Market Share (2019-2020)
Table 57. Japan Optic Neuritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Optic Neuritis Treatment Market Share by Type (2015-2020)
Table 59. Japan Optic Neuritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Optic Neuritis Treatment Market Share by Application (2015-2020)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Product
Table 64. Pfizer Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 65. Pfizer Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Product
Table 69. Sanofi Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 70. Sanofi Recent Development
Table 71. Allergan Company Details
Table 72. Allergan Business Overview
Table 73. Allergan Product
Table 74. Allergan Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 75. Allergan Recent Development
Table 76. Bristol-Meyers Squibb Company Details
Table 77. Bristol-Meyers Squibb Business Overview
Table 78. Bristol-Meyers Squibb Product
Table 79. Bristol-Meyers Squibb Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 80. Bristol-Meyers Squibb Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. Healthy Life Pharma Company Details
Table 87. Healthy Life Pharma Business Overview
Table 88. Healthy Life Pharma Product
Table 89. Healthy Life Pharma Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 90. Healthy Life Pharma Recent Development
Table 91. Fresenius Kabi USA Company Details
Table 92. Fresenius Kabi USA Business Overview
Table 93. Fresenius Kabi USA Product
Table 94. Fresenius Kabi USA Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 95. Fresenius Kabi USA Recent Development
Table 96. Hikama Business Overview
Table 97. Hikama Product
Table 98. Hikama Company Details
Table 99. Hikama Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 100. Hikama Recent Development
Table 101. AdvaCare Pharma Company Details
Table 102. AdvaCare Pharma Business Overview
Table 103. AdvaCare Pharma Product
Table 104. AdvaCare Pharma Revenue in Optic Neuritis Treatment Business (2015-2020) (Million US$)
Table 105. AdvaCare Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Optic Neuritis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Features
Figure 3. Oral Features
Figure 4. Global Optic Neuritis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Optic Neuritis Treatment Report Years Considered
Figure 9. Global Optic Neuritis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Optic Neuritis Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Optic Neuritis Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Optic Neuritis Treatment Market Share by Players in 2019
Figure 14. Global Top Optic Neuritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Optic Neuritis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Optic Neuritis Treatment Revenue in 2019
Figure 16. North America Optic Neuritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Optic Neuritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Optic Neuritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Optic Neuritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Pfizer Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 22. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Sanofi Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 24. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Allergan Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 26. Bristol-Meyers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bristol-Meyers Squibb Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 30. Healthy Life Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Healthy Life Pharma Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 32. Fresenius Kabi USA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Fresenius Kabi USA Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 34. Hikama Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Hikama Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 36. AdvaCare Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. AdvaCare Pharma Revenue Growth Rate in Optic Neuritis Treatment Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed